Study on New Principles of Treatments in Malignant Hematological Diseases, as Acute and Chronic Lymphocytic Leukemia or Multiple Myeloma | Chapter 3 | New Frontiers in Medicine and Medical Research Vol. 3
B-cell chronic lymphocytic leukaemia (B-CLL) is one of the most frequent hematologic cancers, affecting the elderly in particular. It's particularly intriguing because, despite being classified as apathologicalentity and having been studied for decades. The goal of this study is to describe the most recent findings in molecular medicine in terms of therapy for malignant hemopathies that have resulted from the deletion of the P53 gene in the human lymphoma genome. Method: In recent years, it has been demonstrated that Flow Cytometry, Elisa, ICT, and Fluorescence in Situ Hybridization are the best techniques for investigating malignant lymphocytes (FISH). This approach is utilised as an alternative to chromosomal banding, which is a common molecular medicine application. Discussion: Endogenous somatic gene therapy research has recently been a foundation of clinical and therapeutic trials. The DNA is utilised to cure an illness that develops as a result of chromosomal mutations. This ...